Condition: Dry Eye Disease (DED) · Sponsor: Indiana University
This is a prospective, randomized, double-masked, multi-site clinical trial designed to compare the efficacy of SYSTANE® PRO (Alcon Laboratories, Inc.) to MIEBO™ (Bausch + Lomb) in treating symptoms of evaporative dry eye disease (DED). The primary goal is to determine whether SYSTANE® PRO is non-inferior to MIEBO™ after one month of treatment, based on change in Ocular Surface Disease Index (OSDI) scores.
This description comes directly from the study's public registry record.
Anna Tichenor, OD, PhD, FAAO · 812-855-0520 · annatich@iu.edu
Always discuss trial participation with your own doctor first.
| Eye Research Foundation | Newport Beach, California, United States | Recruiting |
| Indiana Universtiy School of Optometry | Bloomington, Indiana, United States | Recruiting |
| Kannarr Eye Care | Pittsburg, Kansas, United States | Recruiting |
| Southern College of Optometry | Memphis, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07243275